Lung Cancer Clinical Trial
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Summary
The purpose of the study is to see if stereotactic radiosurgery/SRS is an effective treatment for people with a new diagnosis of brain metastases from small cell lung cancer/SCLC.
Eligibility Criteria
Inclusion Criteria:
Histologic diagnosis of small cell lung cancer
Radiographic diagnosis of up to 10 brain metastases on contrast-enhanced MRI
Age 18 and above
Performance status KPS 60-100/ECOG 0-2
Female patients must be of non-reproductive potential or have a negative serum pregnancy test at the time of enrollment
The patient or legally authorized representative is able to provide informed consent
Exclusion Criteria:
Unable to undergo contrast-enhanced MRI brain or spine
Leptomeningeal disease confirmed on lumbar puncture, MRI brain, or MRI spine
Pregnant or lactating women
Prior brain-directed radiotherapy
Uncontrolled systemic disease without reasonable systemic therapy options felt likely to result in death as observed on CT or PET/CT imaging, no more than 3 months before study enrollment
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 7 Locations for this study
New York New York, 10065, United States More Info
How clear is this clinincal trial information?